Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01644656 · ClinicalTrials.gov registry record · NA
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
A NA study of Portal Hypertension and Chronic Liver Disease, sponsored by VA Connecticut Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 2
- Study locations
NCT01644656 is a NA study of Portal Hypertension and Chronic Liver Disease that has completed, run by VA Connecticut Healthcare System. The registered enrollment target is 500 participants, above the 153-participant average among 9 other Portal Hypertension trials with a reported enrollment target (227% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT01644656, a NA study of Portal Hypertension and Chronic Liver Disease, has completed, sponsored by VA Connecticut Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
The aim of this diagnostic study is to evaluate the efficacy of ARFI imaging (a specific type of ultrasound) in assessing the pressure of the portal vein (the major vein passing through the liver) and the amount of liver fibrosis in patients with chronic liver disease.
Conditions Studied
Interventions
- DEVICE ARFI ultrasound
Study Locations (2)
Connecticut
- Yale-New Haven Hospital - New Haven
- VA Connecticut Healthcare System - West Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2012-07 |
| Est. Completion | 2018-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01644656
The ClinicalTrials.gov registry entry for NCT01644656 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 153-participant average among 9 other Portal Hypertension trials with a reported enrollment target (227% higher). The listed sponsor is VA Connecticut Healthcare System, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Portal Hypertension appearing as the primary indexed condition, and to 1 intervention - of which ARFI ultrasound is the first listed.
NCT01644656 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT01644656 about?
NCT01644656 is a clinical study titled "Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)". The aim of this diagnostic study is to evaluate the efficacy of ARFI imaging (a specific type of ultrasound) in assessing the pressure of the portal vein (the major vein passing through the liver) and the amount of liver fibrosis in patients with chronic liver disease.
What is the current status of trial NCT01644656?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2012-07. Estimated completion is 2018-09.
What conditions does trial NCT01644656 study?
This clinical trial studies the following conditions: Portal Hypertension, Chronic Liver Disease.
What interventions are being tested in trial NCT01644656?
The interventions under investigation include: ARFI ultrasound (DEVICE).
Who is sponsoring clinical trial NCT01644656?
This trial is sponsored by VA Connecticut Healthcare System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01644656 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Portal Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ultrasound With Subharmonic Imaging and Subharmonic Aided Pressure Estimation (SHAPE) to Identify Portal Hypertension
RECRUITING · NA
-
Evaluation of 3D Overlay During Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure
COMPLETED · NA
-
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
RECRUITING
-
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
RECRUITING · Phase 3
-
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
ACTIVE NOT RECRUITING · Phase 2
-
LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.